West Virginia Code of State Rules
Agency 69 - Health And Human Resources
Title 69 - LEGISLATIVE RULE DEPARTMENT OF HEALTH AND HUMAN RESOURCES
Series 69-07 - Regulations of Opioid Treatment Programs
Section 69-7-44 - Special Populations
Universal Citation: 69 WV Code of State Rules 69-7-44
Current through Register Vol. XLI, No. 38, September 20, 2024
44.1. Behavioral Health Needs.
44.1.a. Each opioid
treatment program shall ensure that patients with behavioral health needs are
identified through the evaluation process and referred for appropriate
treatment.
44.1.b. At all phases of
treatment, the opioid treatment program shall monitor patients during
detoxification withdrawal and recovery for indications of symptoms of
behavioral illness.
44.1.c. Each
opioid treatment program shall establish linkages with behavioral health
providers in the community.
44.1.d.
Each opioid treatment program may provide psychotropic medication management
onsite by appropriately trained medical professionals. Individualized treatment
plans of care shall describe the goals of psychotropic medication management,
which shall be reviewed regularly. The patient's chart and individualized
treatment plan of care shall document regular contact with the prescribing
physician and/or physician extender for the distinct purpose of monitoring
prescribed psychotropic medications.
44.2. HIV Patients.
44.2.a. The opioid treatment program shall
educate all patients regarding HIV/AIDS, testing procedures, confidentiality,
reporting, follow-up care, safer sex, social responsibilities and sharing of
intravenous equipment.
44.2.b. The
program shall establish linkages with HIV/AIDS treatment programs in the
community.
44.3. Pain Patients.
44.3.a. Each opioid treatment
program shall ensure that physicians practicing at the facility are
knowledgeable in the management of opioid dependence in a context of chronic
pain and pain management. The program may not prohibit a patient diagnosed with
chronic pain from receiving medication for either maintenance or withdrawal in
a program setting.
44.3.b. Each
opioid treatment program shall ensure continuity of care and communication
between programs or physicians regarding patients receiving treatment in both
an opioid treatment program and a facility or physician's office for purposes
of pain management, with the patient's written permission. If a patient refuses
permission for the two entities to communicate and coordinate care, the program
shall document refusal and may make clinically appropriate decisions regarding
take-home medication privileges and continuation in treatment.
44.4. Criminal Justice.
44.4.a. Each opioid treatment program shall
establish agreements and develop procedures to coordinate with agents of the
criminal justice system on behalf of patients insofar as permitted by patient
confidentiality requirements.
44.5. Pregnant Patients.
44.5.a. Pregnant women seeking and needing
treatment shall be enrolled in the opioid treatment program and provided
treatment in accordance with guidelines and protocols from approved
authorities.
44.5.b. The opioid
treatment program shall ensure that every pregnant patient has the opportunity
for prenatal care, either onsite or by referral. If the arrangement is by
referral, the program shall have agreements in place, including informed
consent procedures, which ensure exchange of pertinent clinical information
regarding compliance with the recommended plan of medical care.
44.5.c. If not available elsewhere, the
program shall offer a basic instruction on maternal, physical and dietary care
as part of its counseling services and document the provision of the services
in the clinical record.
44.5.d.
With respect to pharmacotherapy for opioid-addicted pregnant women in
medication-assisted therapy, the program shall:
44.5.d.1. Maintenance treatment dosage levels
of pregnant clients shall be maintained at the lowest possible dosage level
that is a medically appropriate therapeutic dose as determined by the medical
director or clinic physician taking the pregnancy into account.
44.5.d.2. Ensure that the initial methadone
dose for a newly admitted pregnant patient and the subsequent induction and
maintenance dosing strategy reflect the same effective dosing protocols used
for all other patients;
44.5.d.3.
Monitor the dose carefully, moving rapidly to supply increased or split dose if
it becomes necessary; and
44.5.d.4.
If a pregnant patient elects to withdraw from methadone, ensure that withdrawal
is not initiated by the clinic before fourteen weeks and after thirty-two weeks
gestation; perform regular fetal assessments as appropriate for fetal age, and
require that withdrawal is supervised by a physician experienced in addiction
medicine.
44.5.e. The
opioid treatment program shall ensure appropriate referral for follow-up and
primary care for the mother and infant.
44.5.f. If a pregnant patient is discharged,
the opioid treatment program shall identify the physician to whom the patient
is being discharged and this information shall be retained in the clinical
record.
44.5.g. The program shall
offer onsite parenting education and training to all male and female patients
who are parents or shall refer interested patients to appropriate alternative
services for the training.
44.5.h.
The program shall offer reproductive health education to all patients and
appropriate referrals for contraceptive services as necessary.
Disclaimer: These regulations may not be the most recent version. West Virginia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
